Blue Jet Healthcare Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 21.96% vs 16.27% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 60.17% vs -22.96% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 52.03% vs -14.69% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is 70.59% vs -92.66% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Blue Jet Health With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

234.67

80.17

154.50

192.72%

Other Operating Income

0.00

Total Operating income

234.67

80.17

154.50

192.72%

Raw Material Cost

92.89

37.86

55.03

145.35%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

9.32

-16.89

26.21

155.18%

Employee Cost

18.48

5.99

12.49

208.51%

Power Cost

0.00

Manufacturing Expenses

-0.01

0.00

-0.01

Selling and Distribution Expenses

0.00

Other Expenses

42.72

24.32

18.40

75.66%

Total Expenditure (Excl Depreciation)

163.40

51.28

112.12

218.64%

Operating Profit (PBDIT) excl Other Income

71.27

28.89

42.38

146.69%

Other Income

22.92

9.62

13.30

138.25%

Operating Profit (PBDIT)

94.19

38.51

55.68

144.59%

Interest

0.58

1.97

-1.39

-70.56%

Exceptional Items

0.00

Gross Profit (PBDT)

93.61

36.54

57.07

156.19%

Depreciation

6.46

1.79

4.67

260.89%

Profit Before Tax

87.15

34.74

52.41

150.86%

Tax

22.81

8.98

13.83

154.01%

Provisions and contingencies

0.00

Profit After Tax

64.34

25.77

38.57

149.67%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

64.34

25.77

38.57

149.67%

Equity Capital

34.69

11.29

23.40

207.26%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

3.71

2.28

1.43

62.72%

Diluted Earnings per share

3.71

2.31

1.40

60.61%

Operating Profit Margin (Excl OI)

30.37%

36.04%

0.00

-5.67%

Gross Profit Margin

39.89%

45.58%

0.00

-5.69%

PAT Margin

27.42%

32.14%

0.00

-4.72%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 234.67 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 21.96% vs 16.27% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -31.07% vs 85.08% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 64.34 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 60.17% vs -22.96% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -41.56% vs 177.68% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 71.27 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 52.03% vs -14.69% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -49.09% vs 163.76% in Mar 2025

Quarterly - Interest

Interest 0.58 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 70.59% vs -92.66% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 1,833.33% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 30.37%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025